Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

Register to chat with this document.

FFR - 6K: Purple Biotech Announces Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress

Company: Purple Biotech Ltd. Date: 2025-06-23 Language: English Register to download

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method: